Get startedLog in
    Picture of Dermapharm Holding SE logo

    DMP — Dermapharm Holding SE News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareBalancedMid CapNeutral
    All News

    Brief: Dermapharm H1 Adj. EBITDA Up At EUR 137 Mln

    Picture of Dermapharm Holding SE logoDermapharm Holding SE
    24/08/2021 06:32
    Aug 24 (Reuters) - DERMAPHARM HOLDING SE  DMPG.DE :
    * ADJUSTED EBITDA UP ALMOST 50%  IN H1 2021
    * H1 ADJUSTED EBITDA ROSE 49 PERCENT TO 137 MILLION EUR
    * H1 EBITDA 135 MILLION EUR VERSUS 86 MILLION EUR YEAR AGO
    * H1 REVENUE ROSE 13 PERCENT TO 428 MILLION EUR
    * CONFIRMS OUTLOOK FOR 2021 OVERALL

Source text for Eikon:  ID:nEQbZ3WS7a 
Further company coverage:  DMPG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Dermapharm Holding SE

    See all news